Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
15.2M
-
Shares change
-
+1.64M
-
Total reported value, excl. options
-
$533M
-
Value change
-
+$58.4M
-
Put/Call ratio
-
0.57
-
Number of buys
-
48
-
Number of sells
-
-16
-
Price
-
$35.09
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2015
77 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2015.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.2M shares
of 170M outstanding shares and own 8.92% of the company stock.
Largest 10 shareholders include FMR LLC (5.86M shares), PRICE T ROWE ASSOCIATES INC /MD/ (962K shares), FEDERATED INVESTORS INC /PA/ (695K shares), BlackRock Fund Advisors (662K shares), Flagship Ventures 2007 General Partner LLC (599K shares), WADDELL & REED FINANCIAL INC (586K shares), VANGUARD GROUP INC (545K shares), TimesSquare Capital Management, LLC (500K shares), JENNISON ASSOCIATES LLC (399K shares), and BRIDGER MANAGEMENT, LLC (381K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.